The advertisement promotes Danziten (nilotinib) tablets, highlighting their inclusion in the NCCN Clinical Practice Guidelines for chronic myeloid leukemia (CML) and emphasizing that there are no meal restrictions associated with their use.
Creative Information
| CID: | 387e20e9-390a-4591-902b-d53136ddbd96 |
| CRID: | 25_2osz2no1 |
| Domain: | gliadel.com |
| Seat: | TTD |
| Size: | 160x600 |
| Bid: | $1.69 |
| Timestamp: | 11/1/2025, 3:11:21 AM |
| Declared IAB Categories: |
Analysis
5 succeeded(100% complete)
| Task | Status | Last Updated | Duration | Actions |
|---|---|---|---|---|
| ad_analysis | success | 11/12/2025, 3:48:21 PM | 6.69s | |
| adomain_analysis | success | 11/12/2025, 4:55:10 PM | 4.58s | |
| adomain_capture | success | 11/12/2025, 4:52:57 PM | 0.15s | |
| ad_render | success | 11/12/2025, 3:48:15 PM | 33.90s | |
| brand_mapping | success | 11/12/2025, 3:01:49 PM | 0.07s | |
Analysis Results
Ad Format: banner
Brands: Gliadel
Sensitive:Pharmaceutical Products
Quality:Adomain not match landing page domain
| Size: | 160x600 | ||||||||||||||||||||||
| Data Transferred: | 1539.52 KB | ||||||||||||||||||||||
| Render Time: | 8.11 Seconds | ||||||||||||||||||||||
| Creative Inferred IAB Categories: |
| ||||||||||||||||||||||
| Creative Inferred IAB Ad Products: |
| ||||||||||||||||||||||
| Domain Inferred IAB Categories: |
| ||||||||||||||||||||||
| Domain Inferred IAB Ad Products: |
| ||||||||||||||||||||||
| Landing Page: | |||||||||||||||||||||||
| Total Ad Size: | 1558.82 KB | ||||||||||||||||||||||
| Requests Made: |
|
Advertiser Domain

Ad Preview
Landing Page

Creatives


